JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Morey, T. E. Articles by Dennis, D. M. Search for Related Content PubMed PubMed Citation Articles by Morey, T. E. Articles by Dennis, D. M. Related Collections Pharmacology

---

ANESTHETIC PHARMACOLOGY

Anesthetic Properties of a Propofol Microemulsion in Dogs

Timothy E. Morey, MD^*, Jerome H. Modell, MD, DSc (Hon)^*, Dushyant Shekhawat, BS, Dinesh O. Shah, PhD^*, Brian Klatt, BS, George P. Thomas, MSc, PhD, Frank A. Kero, BS^*||, Matthew M. Booth, PhD^*, and Donn M. Dennis, MD, FAHA^*¶#

From the Departments of *Anesthesiology, Chemical Engineering, ||Chemistry, ¶Pharmacology and Experimental Therapeutics, and #Psychiatry, University of Florida, Gainesville, Florida; NanoMedex, Inc., Alachua, Florida; and Calvert Laboratories, Inc., Olyphant, Pennsylvania.

Address correspondence and reprint requests to Donn M. Dennis, MD, FAHA, Department of Anesthesiology, University of Florida, PO Box 100254, Gainesville, FL 32610-0254. Address e-mail to DDennis{at}ufl.edu.

Microemulsions of propofol with nanometer droplet diameter are alternatives to soybean macroemulsions for inducing anesthesia, and may have important advantages. We used a propofol (10 mg/mL) microemulsion (particle diameter 24.5 ± 0.5 nm) and a commercial macroemulsion to induce anesthesia in dogs (n = 10) using a randomized, crossover design separated by a 7-day rest interval. The end points were loss of leg withdrawal after a toe pinch and changes in vital signs. Venous blood samples were acquired at multiple times to measure plasma propofol concentrations and indices of erythrocytes, leukocytes, and coagulation. All dogs were rendered insensitive to pain followed by successful recovery without noticeable complications. Comparing indices between microemulsion and macroemulsion formulations, no differences were noted with respect to dose (10.3 ± 1.2 and 9.7 ± 1.6 mg/kg, respectively, P = 0.39), time to induction (1.0 ± 0.1 and 1.0 ± 0.2 min, P = 0.39), time to recovery (17.4 ± 4.6 and 18.2 ± 3.8 min, P = 0.70), heart rate (P = 0.62), arterial blood pressure (P = 0.81), respiratory rate (P = 0.60), hemogram variables, prothrombin time (P = 0.89), activated partial thromboplastin time (P = 0.76), fibrinogen concentration (P = 0.52), platelet concentration (P = 0.55), or plasma propofol concentrations (P = 0.20). Induction with a propofol microemulsion or macroemulsion did not significantly vary with respect to vital signs, the hemogram, clotting variables, and plasma propofol concentrations.

This article has been cited by other articles:

				J. G. Bovill Anesthetic Pharmacology: Reflections of a Section Editor Anesth. Analg., November 1, 2007; 105(5): 1186 - 1190. [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999